Failed to register as Favorite Page
Failed to cancel as Favorite Page
This page is already registered as a Favorite Page
You can't add your company to your favorites.
Latest update： 20/06/2017 19:24:02
Okinawa Protein Tomography Ltd.
We provide structure analysis services for biopolymer visualization.
We provide structure analysis services that visualize proteins and other biopolymers at the single-molecule level. Our tomography-based services combine cryo-electron microscopy and a 3D structure analysis program (COMET) developed by OIST. We deliver the results of analyzing a 1-µg sample solution. We can analyze a sample without crystallization to ascertain structural changes of complex proteins. Our company has provided structure analysis services for protein complexes for Sysmex Corporation and structure analysis services for intercellular tight junctions for Ehime University.
[Company strength] Our company was established as OIST’s first startup. Our office is in OIST, and we receive support from Okinawa Prefecture as well as expectations for our activities. We have concluded an exclusive licensing agreement with OIST regarding related patents and software. OIST is continuously adding functions and making various improvements to the software, including its resolution. We are the world’s only provider and global pioneer of structure analysis services based on tomography. [Business description] Our company provides structure analysis services that visualize proteins and other biopolymers at the single-molecule level. Our tomography-based services combine cryo-electron microscopy and a 3D structure analysis program (COMET) developed by the Okinawa Institute of Science and Technology Graduate University (OIST). We receive a trace (1 µg) of a sample solution from a customer and deliver the analysis results. [Industry] Special and technical services [Representative's message] Our aim from the beginning of our establishment has been to be a global company born in Okinawa. We anticipate that overseas customers will be quicker to decide to implement new technologies. It takes time until a new technology is accepted in a market. We aim to receive our first orders from customers outside Japan to begin with. Our targets are Europe, the USA, and Singapore. We do not know where our business will start from among these three big markets, but we are in a hurry to make a breakthrough. We will start with a service provision business model. The ownership of the analysis results is clearly defined, so we will have no problems with intellectual property, which often causes issues in overseas business. [Company structure for market development/overseas expansion] Our company has experience with sales activities and receiving orders in the Japanese market, but we think now is the time for us to develop relationships with agencies. We understand the importance of overseas markets, and we started marketing activities outside Japan last year. We will continue to participate in biotechnology-related exhibitions and trade fairs sponsored by JETRO. Our target markets are Europe, the USA, and Singapore. We have already concluded a sales consultation contract in Europe with a Swedish company and are our continuing sales activities. We have concluded a non-disclosure agreement (NDA) with a company in Singapore as a candidate agency. We have not made any decisions about the USA. Our president is in charge of sales channel cultivation and overseas business expansion, but we recently employed overseas marketing staff. [Awards and media coverage] [Awards] [Media] Ryukyu Shimbun, Okinawa Times, Nihon Keizai Shimbun, and Nikkan Kogyo Shimbun, "OIST Startup Established" (July 31, 2014); Nihon Keizai Shimbun "Okinawa Zoom-in: New Analysis Method; Business Opportunity in Drug Discovery" (August 23, 2014); "OIST Integrates Biological and Physical Research" (September 1, 2014); Okinawa Times, "Seven Companies Selected for New Industry Support" (September 24, 2014); Okinawa Times, "OIST Technology Steadily Sinks In" (September 2, 2015); Ryukyu Shimbun, Okinawa Times, Nihon Keizai Shimbun, and Nikkan Kogyo Shimbun, "Okinawa Development Finance Corporation Invests 80 Million Yen in Okinawa Protein Tomography" (September 25, 2015).
This company is recommended by the following support organizations.
- Kyushu Head Office, SMRJ